martes, 13 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 17, 2026

Stock market today: Dow, S&P 500, Nasdaq waver in volatile trading as AI anxiety lingers

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, Nasdaq waver in volatile trading as AI anxiety lingers US stocks wavered Tuesday in volatile trading as Wall Street continued assessing the AI jitters that have hammered markets in recent weeks…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Corporate profits are rising while labor income keeps falling, fueling a K-shaped economy; the split is consistent and reinforced by the rally in financial and real assets concentrated among higher- and middle-income households.

    80% confidence
  • BofA analysts questioned whether rising productivity data represents real improvements in labor productivity given that economic gains are aggregating in corporate profits while wages fall.

    80% confidence
  • Fed funds rate-cut bets look stretched, leaving room for a near-term USD-positive repricing, citing resilient growth and underlying inflation that has stalled above the Fed's 2% target.

    80% confidence
  • Iran reached a general agreement with the US on a set of guiding principles, based on which they will proceed and move toward drafting a potential agreement.

    80% confidence
  • The Netflix merger is in the best interests of WBD shareholders due to the tremendous value it provides and a clear path to achieve regulatory approval.

    80% confidence
  • It remains to be seen whether wages and salaries recoup some of their lost ground relative to corporate profits; higher profits relative to wages are yet another driver of a K-shaped economy.

    80% confidence
  • Weak consumer sentiment, heightened uncertainty, and significant volatility have weighed on category growth and impacted consumer purchase patterns, contributing to the lowered 2026 outlook.

    80% confidence
  • The Americans want to negotiate over Iran's nuclear energy with the outcome being that Iran does not have this energy; if that is the case, there is no room for negotiation.

    80% confidence
  • Key investor topics for Nvidia earnings include higher component costs impacting mid-70s percentage gross margins, updates on Anthropic/OpenAI investments, inference competition, and impact of the Groq licensing agreement on Nvidia's product roadmap.

    80% confidence
  • General Mills is making meaningful progress in strengthening its remarkability to position the business for long-term sustainable growth, but progress has come amid a more challenging backdrop.

    80% confidence

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,372 documentos fuente archivados
Consulta estos datos → isubstrate.com